Streetbeat News

Partnerships

MYGN

Myriad Genetics, Inc. has launched the Myriad Collaborative Research Registry (MCRR), formerly known as the Precise Treatment Registry. The MCRR is a comprehensive pan-cancer registry with data from over one million patients, encompassing germline and tumor testing results from Myriad's cancer products. This registry is one of the largest of its kind and is freely available for research to promote clinical data sharing and advance the field of precision medicine.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:03 pm

RXRX

Recursion Pharmaceuticals has partnered with Enamine to create screening libraries using Recursion's MatchMaker protein-ligand interaction predictions. These libraries will be designed from Enamine's vast library of 36 billion compounds, focusing on up to 100 biological targets. Enamine will have the option to sell these libraries to customers and will co-brand them under both Enamine and MatchMaker trademarks.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:01 pm

MSFT

Bill Gates, co-founder of Microsoft Corp. (NASDAQ:MSFT), expressed optimism about AI's role in healthcare breakthroughs. He highlighted five areas where AI could have a significant impact: combating antibiotic resistance, personalized tutoring, treating high-risk pregnancies, assessing HIV risk, and improving access to medical information. Despite global challenges, Gates believes AI will accelerate research and innovation, particularly in healthcare.

Portfolio Pulse from Rounak Jain

December 20, 2023 | 12:57 pm

EOSE

Eos Energy Enterprises (EOSE) has partnered with Partner4Work to create a $500K training program aimed at upskilling the current and future workforce for Eos' manufacturing facility in the Mon Valley. This initiative is expected to enhance the skill set of employees, aligning with the company's growth and operational efficiency goals.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:44 pm

ABSI

Absci Corporation (ABSI) has partnered with PrecisionLife to develop a joint portfolio of AI-enabled drug pipeline projects. The collaboration aims to discover and develop biotherapeutics for up to five targets and indications, focusing on chronic diseases with unmet clinical needs. Both companies will share in the potential value of the programs developed.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:33 pm

INKT

MiNK Therapeutics has entered into a collaboration with ImmunoScape to accelerate the identification of novel TCRs and the development of TCR-based therapeutics. This partnership aims to enhance MiNK's pipeline of TCR therapeutics for cancer and other diseases. ImmunoScape's deep immunomics platform will be utilized to identify and analyze TCRs, potentially leading to more effective treatments.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:32 pm

PRZO

ParaZero Technologies Ltd. (NASDAQ:PRZO) has announced the successful completion of a drone safety solution for a Fortune 500 automotive manufacturer's proprietary drone program. The project involved the development of a custom variant of ParaZero's SafeAir™ drone safety system, for which the company has received full payment.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:18 pm

DNA

OneOne Biosciences has entered into a partnership with Ginkgo Bioworks to further develop its platform and advance its nitrogen fixation microbial product. This collaboration aims to enhance OneOne Biosciences' capabilities in creating sustainable agricultural solutions.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:08 pm

TAK

Takeda Pharmaceutical Company has secured a two-year contract with Canadian Blood Services for the supply of GLASSIA, a treatment for a rare form of emphysema. This deal may positively impact Takeda's revenues and market presence in Canada.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:04 pm

LITM

ACME Lithium has entered into an option agreement with Snow Lake Lithium (LITM) regarding its Manitoba Lithium Project. This agreement allows Snow Lake Lithium to earn an interest in the project, which could potentially enhance its lithium production capabilities.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 11:34 am